Duodenal ulcer relapse after eradication of Campylobacter pylori.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 2564914)

Published in Lancet on April 15, 1989

Authors

B J Marshall, J R Warren, C S Goodwin

Articles by these authors

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet (1984) 32.58

Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust (1985) 10.75

Campylobacter pyloridis, gastritis, and peptic ulceration. J Clin Pathol (1986) 9.90

Pyloric Campylobacter infection and gastroduodenal disease. Med J Aust (1985) 8.49

Evaluation of cultural techniques for isolating Campylobacter pyloridis from endoscopic biopsies of gastric mucosa. J Clin Pathol (1985) 6.78

Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet (1989) 6.58

Helicobacter pylori and peptic ulcer disease: evolution to revolution to resolution. AJR Am J Roentgenol (1997) 4.99

Campylobacter pyloridis and gastritis. J Infect Dis (1986) 4.95

Rapid urease test in the management of Campylobacter pyloridis-associated gastritis. Am J Gastroenterol (1987) 4.70

Unusual cellular fatty acids and distinctive ultrastructure in a new spiral bacterium (Campylobacter pyloridis) from the human gastric mucosa. J Med Microbiol (1985) 4.05

Restriction endonuclease analysis of the genome of Campylobacter pylori with a rapid extraction method: evidence for considerable genomic variation. J Infect Dis (1988) 3.96

The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis. J Antimicrob Chemother (1986) 3.94

Inhibition of haemaggregation by lepromin and other mycobacterial substances. Nature (1967) 3.84

Enzyme-linked immunosorbent assay for Campylobacter pyloridis: correlation with presence of C. pyloridis in the gastric mucosa. J Infect Dis (1987) 3.69

Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations. Aliment Pharmacol Ther (2012) 2.94

Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up. Lancet (1994) 2.90

Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies. J Clin Pathol (1988) 2.52

Pyloric campylobacter serology. Lancet (1984) 2.43

Helicobacter nemestrinae sp. nov., a spiral bacterium found in the stomach of a pigtailed macaque (Macaca nemestrina) Int J Syst Bacteriol (1991) 2.37

Urea hydrolysis in patients with Campylobacter pyloridis infection. Lancet (1986) 2.26

Comparison of technics for the isolation of T-strain mycoplasmas. Nature (1969) 2.02

Cross-contamination of specimens with Mycobacterium tuberculosis: clinical significance, causes, and prevention. Am J Clin Pathol (1998) 1.94

When is Helicobacter pylori infection acquired? Gut (1993) 1.94

Computer printing and filing of microbiology reports. 1. Description of the system. J Clin Pathol (1976) 1.92

Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis. Digestion (1987) 1.87

Bacillus macquariensis n.sp., a psychrotrophic bacterium from sub-antarctic soil. J Gen Microbiol (1966) 1.85

Effects of rate of infusion and probenecid on serum levels, renal excretion, and tolerance of intravenous doses of cefoxitin in humans: comparison with cephalothin. Antimicrob Agents Chemother (1974) 1.76

Cefuroxime: pharmacokinetics after a short infusion, and in vitro activity against hospital pathogens. J Antimicrob Chemother (1977) 1.70

Metronidazole susceptibility testing for Helicobacter pylori: comparison of disk, broth, and agar dilution methods and their clinical relevance. J Clin Microbiol (1993) 1.70

Intracellular vacuolization caused by the urease of Helicobacter pylori. J Infect Dis (1990) 1.70

Evaluation of the Vitek 2 system for rapid identification of clinical isolates of gram-negative bacilli and members of the family Streptococcaceae. Eur J Clin Microbiol Infect Dis (2002) 1.54

Helicobacter pylori is not the cause of sudden infant death syndrome (SIDS). Am J Gastroenterol (2001) 1.48

The nature of the enzymically catalysed binding of glucose to the protein coat of Colpoda steinii cysts. Biochem J (1969) 1.47

The role of Helicobacter pylori in acid-peptic disease. Am J Med Sci (1993) 1.42

Computer printing and filing of microbiology reports. 2. Evaluation and comparison with a manual system, and comparison of two manual systems. J Clin Pathol (1976) 1.40

Will antibacterial chemotherapy be efficacious for gastritis and peptic ulcer? J Antimicrob Chemother (1986) 1.40

The use of the voluntary muscle test in leprosy neuritis. Lepr Rev (1968) 1.40

Effects of various gases on the survival of dried bacteria during storage. Appl Microbiol (1973) 1.40

Practical advice on eradicating Helicobacter pylori infection. Postgrad Med (1999) 1.38

Control of methicillin-resistant Staphylococcus aureus (MRSA) in an Australian metropolitan teaching hospital complex. Med J Aust (1985) 1.37

Hepatic and renal effects of peroxisome proliferators: biological implications. Ann N Y Acad Sci (1982) 1.36

Evidence for cell-receptor activity in lymphocyte stimulation by staphylococcal enterotoxin. J Immunol (1975) 1.35

Response of Campylobacter pyloridis to antibiotics, bismuth and an acid-reducing agent in vitro--an ultrastructural study. J Med Microbiol (1987) 1.35

Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis (1995) 1.33

Iron transport in Mycobacterium smegmatis: the role of mycobactin. Biochim Biophys Acta (1972) 1.28

Culture of Helicobacter pylori from a gastric string may be an alternative to endoscopic biopsy. J Clin Microbiol (2000) 1.24

Tolerance of bacteria to high concentrations of NaCl and glycerol in the growth medium. Appl Microbiol (1971) 1.22

Iron transport in Mycobacterium smegmatis: a restricted role for salicylic acid in the extracellular environment. Biochim Biophys Acta (1974) 1.21

Symposium on bacterial spores: IX. Biophysical analysis of the spore. J Appl Bacteriol (1970) 1.19

An enzymically catalysed reaction between D-glucose and the protein cyst coat of the ciliate Colpoda steinii. Biochem J (1970) 1.18

The 14C-urea breath-test for the detection of gastric Campylobacter pylori infection. Med J Aust (1989) 1.13

Accurate diagnosis of Helicobacter pylori. Serologic testing. Gastroenterol Clin North Am (2000) 1.08

High-level gentamicin resistance in Enterococcus faecalis bacteremia. J Infect Dis (1991) 1.07

Enterotoxigenic Aeromonas hydrophila and diarrhoea in adults. Med J Aust (1983) 1.07

Proposed link between Helicobacter pylori and sudden infant death syndrome. Med Hypotheses (1997) 1.07

Cerebrospinal fluid broth culture isolates: their significance for antibiotic treatment. Am J Clin Pathol (1997) 1.07

Accurate diagnosis of Helicobacter pylori. Urease tests. Gastroenterol Clin North Am (2000) 1.07

Ultrastructure of another spiral organism associated with human gastritis. Dig Dis Sci (1989) 1.05

Interaction of Campylobacter pyloridis with human immune defence mechanisms. J Med Microbiol (1987) 1.04

Long-term follow-up of gastric histology after Helicobacter pylori eradication. J Gastroenterol Hepatol (1996) 1.03

Gastroduodenal mucus gel thickness in patients with Helicobacter pylori: a method for assessment of biopsy specimens. Am J Gastroenterol (1991) 1.03

Properties of hypolipidemic peroxisome proliferators in the lymphocyte [3H]thymidine and Salmonella mutagenesis assays. Cancer Res (1980) 1.03

Microdose 14C-urea breath test offers diagnosis of Helicobacter pylori in 10 minutes. Am J Gastroenterol (1996) 1.01

Campylobacter pylori colonizing heterotopic gastric tissue in the rectum. Am J Clin Pathol (1990) 0.99

Antigenicity of formaldehyde-inactivated staphylococcal enterotoxin B. J Immunol (1973) 0.99

Phthalate esters as peroxisome proliferator carcinogens. Environ Health Perspect (1982) 0.98

Biological activity and complementation of the two peptides of staphylococcal enterotoxin B formed by limited tryptic hydrolysis. J Biol Chem (1975) 0.97

Salicylic acid biosynthesis and its control in Mycobacterium smegmatis. Biochim Biophys Acta (1972) 0.97

Campylobacter pylori infection: diagnosis and therapy. Med J Aust (1989) 0.96

Gastritis and gastric cancer. Western countries. Gastroenterol Clin North Am (2000) 0.96

Scope and consequences of peptic ulcer disease. How important is asymptomatic Helicobacter pylori infection? Postgrad Med (1999) 0.95

How to treat Helicobacter pylori. First-line, second-line, and future therapies. Gastroenterol Clin North Am (2000) 0.94

Differentiation and DNA synthesis in pancreatic acinar carcinoma of rat. Cancer Res (1980) 0.94

Erysipelothrix septicaemia. Br Med J (1973) 0.93

Effect of single peptide bond scission by trypsin on the structure and activity of staphylococcal enterotoxin B. J Biol Chem (1973) 0.93

Radiation dose estimates for the carbon-14-labeled urea breath test. J Nucl Med (1993) 0.93

Occupational exposure to Helicobacter pylori for the endoscopy professional: a sera epidemiological study. Am J Gastroenterol (1994) 0.93

Duodenal bulb biopsy findings for patients with non-ulcer dyspepsia with or without Campylobacter pylori gastritis. Mod Pathol (1990) 0.90

An outbreak of common colds at an Antarctic base after seventeen weeks of complete isolation. J Hyg (Lond) (1973) 0.89

Influence of soluble haemagglutinins on adherence of Helicobacter pylori to HEp-2 cells. J Med Microbiol (1991) 0.88

Usefulness of serological IgG antibody determinations for confirming eradication of Helicobacter pylori infection. Am J Gastroenterol (1999) 0.88

Polymyxin B suppresses the endotoxin inhibition of concanavalin a-mediated erythrocyte agglutination. Infect Immun (1982) 0.87

Spiral bacteria of the gastric antrum. Med J Aust (1984) 0.87

Soluble and cell-associated haemagglutinins of Helicobacter (Campylobacter) pylori. J Med Microbiol (1990) 0.87

Effect of urea on the circular dichroism of lysozyme. J Biol Chem (1972) 0.86

Colistin-sensitive Proteus organisms: including indole-negative Proteus vulgaris, non-swarming on first isolation. Br J Exp Pathol (1971) 0.86

Peptic ulcer: an infectious disease? Hosp Pract (Off Ed) (1987) 0.86

Conversion of chorismic acid and isochorismic acid to salicylic acid by cell-free extracts of Mycobacterium smegmatis. Biochim Biophys Acta (1971) 0.86

The use of in-vitro sensitivity testing to predict clinical response of recurrent herpes simplex to suppressive oral acyclovir. J Antimicrob Chemother (1988) 0.85

Inhibition of ConA erythroagglutination by alkali-treated lipopolysaccharide. Exp Cell Res (1977) 0.85